iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Shares Down 0.4% – Should You Sell?

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE)’s share price fell 0.4% during trading on Wednesday . The stock traded as low as $35.64 and last traded at $35.67. 9,724 shares were traded during mid-day trading, an increase of 4% from the average session volume of 9,369 shares. The stock had previously closed at $35.83.

iShares LifePath Target Date 2045 ETF Price Performance

The business has a 50 day moving average price of $34.74 and a 200 day moving average price of $32.69. The stock has a market capitalization of $37.10 million, a PE ratio of 20.03 and a beta of 0.90.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Citadel Advisors LLC increased its position in shares of iShares LifePath Target Date 2045 ETF by 25.6% during the fourth quarter. Citadel Advisors LLC now owns 11,277 shares of the company’s stock valued at $348,000 after acquiring an additional 2,302 shares in the last quarter. Geneos Wealth Management Inc. purchased a new stake in iShares LifePath Target Date 2045 ETF during the 1st quarter valued at $34,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of iShares LifePath Target Date 2045 ETF in the 4th quarter worth $27,000.

About iShares LifePath Target Date 2045 ETF

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.